Intellia Therapeutics (NTLA) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.28
-1.13
-0.98
-0.83

Details

Expected EPS
-0.9549
Actual EPS
-0.83
Surprise EPS
0.12
Surprise Percent
+13.08%

Description

Intellia Therapeutics (NTLA) has reported earnings of -0.83 per share for Q1 2026.

0 Comments

Share your thoughts